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benzoatAbstract A simple, sensitive, precise and speciﬁc high performance liquid chromatography method
was developed and validated for the determination of rizatriptan in rizatriptan benzoate tablet. The
separation was carried out by using a mobile phase consisting of acetonitrile: pH 3.4 phosphate buf-
fer in ratio of 20:80. The column used was Zorbax SB CN 250 mm · 4.6 mm, 5 l with a ﬂow rate of
1 ml/min using UV detection at 225 nm. The retention time of rizatriptan and benzoic acid was
found to be 4.751 and 8.348 min respectively. A forced degradation study of rizatriptan benzoate
in its tablet form was conducted under the condition of hydrolysis, oxidation, thermal and photol-
ysis. Rizatriptan was found to be stable in basic buffer while in acidic buffer was found to be
degraded (water bath at 60 C for 15 min). The detector response of rizatriptan is directly propor-
tional to concentration ranging from 30% to 160% of test concentration i.e. 15.032 to 80.172 mcg/
ml. Results of analysis were validated statistically and by recovery studies (mean recovery = 99.44).
The result of the study showed that the proposed method is simple, rapid, precise and accurate,
which is useful for the routine determination of rizatriptan in pharmaceutical dosage forms.
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dewar, C.K. et al., Stability ind
e in tablet. Arabian Journal ofC1. Introduction
Rizatriptan benzoate is N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-
ylmethyl)-1H-indol-3-yl]ethanamine. It is an anti migraine
drug, which selectively activates 5-HT1B/1D receptors. Physi-
cal properties are white to off white crystalline powder, soluble
in water, melting point 178–180, and stable under ordinary
condition. So far, no method has been reported for the estima-
tion of rizatriptan in rizatriptan benzoate, hence I attempted to
develop a simple, accurate economical and analytical method.
A study of forced degradation of rizatriptan was also reported.ing Saud University.
icating method development and validation of assay method for
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Figure 1 Rizatriptan benzoate.
Figure 2 HPLC C
Figure 3 Linearity plot for rizatriptan.
Table 1 Linearity.
Spike level in % Concentration of rizatriptan in mcg/ml Peak areas
30 15.032 1281515
50 25.054 2105110
80 40.086 3354257
100 50.108 4181675
120 60.129 5032026
140 70.151 5839565
160 80.172 6653218
Slope 82660
y-intercept 40355
r-value 0.99998
RSS 699915125
2 C.K. Gadewar et al.
Please cite this article in press as: Gadewar, C.K. et al., Stability
the estimationof rizatriptan benzoate in tablet.Arabian JournaThis paper describes validated HPLC for the estimation of
rizatriptan using a mobile phase consisting of acetonitrile:
pH 3.4 phosphate buffer in ratio of 80:20. The column used
was CN 250 mm · 4.6 mm, 5 l with a ﬂow rate of 1 ml/min
using UV detection at 225 nm.
2. Materials and methods
2.1. Equipment
HPLC equipped with a pump, injector and PDA detector
Waters 2695, 2996, HPLC equipped with a pump, injector
and UV detector, Waters 2695, 2487, HPLC equipped with a
pump, injector and UV detector, Agilent 1200 series, Bal-hrom
ind
l of Cance-Sartorius, Mettler Toledo, Photo stability chamber-New-
tronic, Oven-Skan.
2.2. Materials
Rizatriptan benzoate standard (Alkem), tablets were procured
from a local market. Potassium dihydrogen phosphate
(Merck), Acetonitrile (Merck) Orthophosphoric acid (Merck),
Milli Q water, Hydrogen (Merck) Hydrochloric acid (Merck),
Sodium hydroxide (Merck), and Column Zorbax SB CN
250 · 4.6 mm, 5 l.
Preparation of 0.01 M potassium dihydrogen phosphate
buffer pH 3.4:
Dissolve 2.7218 g of potassium dihydrogen orthophosphate
into 2000 ml water, mix and adjust the pH at 3.4 with ortho-
phosphoric acid solution (Mix 10 ml orthophsophoric acid
(88%) into 100 ml water), ﬁlter through a 0.45 l nylon ﬁlter,
mix and degas.
Preparation of mobile phase.
Mix the above buffer and acetonitrile in the ratio of 80:20,
and degas.
Use suitable high performance liquid chromatography
equipped with the following.
Column: Zorbax SB CN 250 · 4.6 mm, 5 l.
Flow rate: 1.0 ml/minatogram of standard.
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Figure 4 Purity plot of control sample.
Table 2 Accuracy.
Level no./spike level in % Actual Amount of rizatriptan added in mg Amount of Rizatriptan found in mg % Recovery
50 4.94 4.92 99.66
100 10.00 9.95 99.49
150 14.99 14.81 98.79
Over all % RSD 0.28
Stability indicating method development and validation of assay method for the estimation 3Wavelength: 225 nm
Injection volume: 10 ll
Column oven temperature: 25 C
Sample compartment temp: 25 C
Run time: 12 min
Diluent: mobile phase
Preparation of standard Solution:
Weigh and transfer accurately about 73 mg (equivalent to
50 mg of rizatriptan) of rizatriptan benzoate working standard
into a 100 ml volumetric ﬂask. Dissolve and dilute to the re-
quired volume with diluent. Further dilute 5 ml of the above
standard solution to 50 ml with diluent.
Preparation of sample solution for 10 mg:
Weigh and transfer ﬁve tablets into a 250 ml volumetric
ﬂask. Add 180 ml of diluent shake well and sonicate for
15 min with intermittent shaking and dilute to the required
volume with diluent. Filter the required amount of solution
through a 0.45 l PVDF/nylon ﬁlter.
Further dilute 5 ml of the above standard solution to 20 ml
with diluent.
Procedure:
Separately inject 10 ll of blank, standard solution (ﬁve rep-
licate injections) and sample solution into the chromato-
graphic system. Record the chromatograms and measure the
peak area count for rizatriptan peak.
The retention time of rizatriptan peak is about 5 min.
Disregard the peak area count of benzoic acid at the reten-
tion time of about 9.2 min (RRT about 1.9).Please cite this article in press as: Gadewar, C.K. et al., Stability ind
the estimation of rizatriptan benzoate in tablet. Arabian Journal ofCEvaluation of system suitability:
From standard solution:
(1) The % RSD for the peak areas of rizatriptan from ﬁve
replicate injections should not be more than 2.0.
(2) The tailing factor for rizatriptan should be not more
than 2.0.
3. Validation method
3.1. Linearity
The linearity of rizatriptan was performed using the standard
solution in the range of 15.032–80.172 mcg/ml (about 30–
160% of test concentration). A graph was plotted with concen-
tration (in mcg/ml) on x-axis and peak areas of rizatriptan on
y-axis. Slope, y-intercept, correlation coefﬁcient (r-value) and
residual sum of squares (RSS) were determined Fig. 3. The re-
sults are tabulated in Table 1:(See Figs. 1, 2 and 4)
3.2. Accuracy
A known amount of rizatriptan benzoate API working stan-
dard was spiked to 50%, 100% and 150% in 10 mg tablets uni-
formity of dosage units test concentration. The amount of
rizatriptan was quantiﬁed as per the test method. The %icating method development and validation of assay method for
hemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.036
Table 4 Forced Degradation.
Condition % Assay % Degradation
Untreated sample 98.11 –
Acid-treated sample 93.99 4.20
Base-treated sample 95.35 2.81
Peroxide-treated sample 95.21 2.96
Heat-treated sample 99.53 #
UV–visible treated sample 96.41 1.73
Table 3 Robustness.
S. No. I (20 C) II (30 C) III (0.9 ml) V (1.1 ml) V (223 nm) VI (227 nm) VII VIII IX (3.5 pH) X (3.3 pH)
1 101.70 101.06 100.41 102.12 100.31 100.48 100.30 100.51 100.85 101.51
2 101.97 100.92 100.82 101.58 100.07 100.16 100.77 100.57 101.31 101.45
3 101.14 102.86 101.00 101.42 101.66 101.71 99.33 98.74 100.48 101.20
%RSD 0.61 0.78 0.51 0.63 0.65 0.63 0.73 0.87 0.52 0.53
4 C.K. Gadewar et al.recovery was calculated from the amount found and the actual
amount added. The results are tabulated in Table 2.
3.3. Robustness
Robustness of the method was veriﬁed by deliberately varying
the following instrumental conditions.Figure 6 HPLC chromatogra
Figure 5 HPLC chromatogr
Please cite this article in press as: Gadewar, C.K. et al., Stability ind
the estimationof rizatriptan benzoate in tablet.Arabian Journal of CBy changing the ﬂow rate by ±10%, by changing the tem-
perature by ±5 C, by changing the wavelength by ±2 nm, by
changing the organic content by ±2% (absolute), and by
changing the pH of buffer in mobile phase by ±0.1 units.
The results are tabulated in Table 3.
4. Forced degradation
Forced degradation study was carried out by treating the sam-
ple under the following conditions. (Table 4 and Figs. 5–9)
(a) Degradation by hydrochloric acid (acid treated sample)
The sample was treated with 5 ml of 1 N hydrochloric acid
and kept on a water bath at 60 C for 20 min. The treated
sample solution was analyzed as per the test method.
(b) Degradation by sodium hydroxide (base treated sample)m of base treated sample.
am of acid treated sample.
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Figure 7 HPLC chromatogram of peroxide treated sample.
Figure 8 HPLC chromatogram of heat treated sample.
Figure 9 HPLC chromatogram of UV visible treated sample.
Table 5 Summary of system suitability.
Name of experiment Tailing factor %RSD
System precision, 1.4 0.13
Method precision 1.3 0.27
Ruggedness 1.08 0.10
Filter paper selection study 1.15 0.03
Speciﬁcity 1.3 0.18
Stability indicating method development and validation of assay method for the estimation 5The sample was treated with 5 ml of 1 N sodium hydroxide
and kept on a water bath at 60 C for 15 min. The treated
sample solution was analyzed as per the test method.
(c) Degradation by hydrogen peroxide (peroxide treated
sample)
The sample was treated with 5 ml of 50% hydrogen perox-
ide solution and kept on water bath at 60 C for 5 min.
The treated sample solution was analyzed as per the test
method.Please cite this article in press as: Gadewar, C.K. et al., Stability indicating method development and validation of assay method for
the estimation of rizatriptan benzoate in tablet. Arabian Journal ofChemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.036
6 C.K. Gadewar et al.(d) Degradation by thermal (heat treated sample)
The sample was kept in an oven at 105 C for about 30 h.
The treated sample was analyzed as per the test method.
(e) Degradation by UV–Visible light (UV–visible treated
sample)
The sample was exposed to UV light of about 200 w h/
square meter and to visible light for about 1.2 million lux
hours in photo stability chamber. The treated sample was
analyzed as per the test method. (See Table 5).
5. Results and discussion
In order to develop an effective method for the analysis of the
drugs in pharmaceutical formulations, preliminary tests were
performed in order to select adequate and optimum condi-
tions. Parameters such as detection of wavelength, ideal mobile
phase and their proportions, optimum pH and concentration
of standard solution were studied. The method was developed
with Column Zorbax SB CN 250 · 4.6 mm, 5 l using ﬂow rate:
1.0 ml/min, wavelength 225 nm at room temperature. The lin-
earity of rizatriptan was performed using the standard solution
in the range of 15.032 mcg/ml to 80.172 mcg/ml (about 30–
160% of test concentration).
6. Conclusion
The HPLC method for the assay of rizatriptan in rizatriptan
benzoate tablet was found to be simple, precise, accurate, rapid
and validated. The mobile phase is simple to prepare and eco-
nomical. The sample recoveries in formulation were in good
agreement with their label claim. Hence it can be easily and con-
veniently adopted for a routine analysis of rizatriptan in tablet.Please cite this article in press as: Gadewar, C.K. et al., Stability ind
the estimationof rizatriptan benzoate in tablet.Arabian Journal of CURLs
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